Cytokines and Depressive Symptoms Among Adolescents - PubMed (original) (raw)

Cytokines and Depressive Symptoms Among Adolescents

Cherry Y Leung et al. Biol Res Nurs. 2025 Jul.

Abstract

Background: Inflammation has been linked to an increased risk of depression, but there is limited and conflicting research on the role of inflammatory markers in adolescent depression. The purpose of this study was to examine associations between cytokines TNF-α, IL-1β, IL-6, and IL-8 and depression among a community-based sample of adolescents (13-19 years of age). Methods: Salivary samples were self-collected by adolescents for assay of cytokines. The Patient Health Questionnaire-9 (PHQ-9) was used to measure depressive symptoms and clinical depression, where a score ≥11 indicated the threshold for experiencing clinical depression. Multiple linear and logistic regression models were used to examine the relationships between cytokines and depression, adjusting for age, sex, ethnicity, income, and body mass index. Results: The mean age of the 83 participants was 15.86 years. Eight participants screened positive for depression; the mean depressive symptom score was 5.11. Higher levels of IL-6 (Coef = 1.33, p < .001) and IL-8 (Coef = 0.69, p = .025) were associated with more frequent depressive symptoms while higher levels of TNF-α (OR = 2.50, p = .002), IL-1β (OR = 1.98, p = .001), and IL-8 (OR = 2.44, p = .008) were associated with greater odds of meeting criteria for clinical depression. Conclusions: Future research should focus on factors that induce higher cytokine levels and the mechanisms underlying their effects on depression. Cytokines assessed in this study may ultimately have implications as methods for depression screening or targets for biologic interventions to prevent and treat adolescent depression.

Keywords: adolescence; cytokines; depression; depressive symptoms; inflammatory biomarkers.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Albert P. R. P. (2015). Why is depression more prevalent in women? Journal of Psychiatry & Neuroscience, 40(4), 219–221. 10.1503/jpn.150205 -DOI -PMC -PubMed
    1. Alvarez A. M., DeOcesano-Pereira C., Teixeira C., Moreira V. (2020). IL-1β and TNF-α modulation of proliferated and committed myoblasts: IL-6 and COX-2-derived prostaglandins as key actors in the mechanisms involved. Cells, 9(9), 2005. 10.3390/cells9092005 -DOI -PMC -PubMed
    1. Benros M. E., Waltoft B. L., Nordentoft M., Ostergaard S. D., Eaton W. W., Krogh J., Mortensen P. B. (2013). Autoimmune diseases and severe infections as risk factors for mood disorders: A nationwide study. JAMA Psychiatry, 70(8), 812–820. 10.1001/jamapsychiatry.2013.1111 -DOI -PubMed
    1. Bentley K. H., Sakurai H., Lowman K. L., Rines-Toth L., McKowen J., Pedrelli P., Evins A. E., Yule A. M. (2021). Validation of brief screening measures for depression and anxiety in young people with substance use disorders. Journal of Affective Disorders, 282, 1021–1029. 10.1016/j.jad.2021.01.005 -DOI -PMC -PubMed
    1. Bernhard S., Hug S., Stratmann A. E. P., Erber M., Vidoni L., Knapp C. L., Thomass B. D., Fauler M., Nilsson B., Nilsson Ekdahl K., Fohr K., Braun C. K., Wohlgemuth L., Huber-Lang M., Messerer D. A. C. (2021). Interleukin 8 elicits rapid physiological changes in neutrophils that are altered by inflammatory conditions. Journal of Innate Immunity, 13(4), 225–241. 10.1159/000514885 -DOI -PMC -PubMed

MeSH terms

Substances

LinkOut - more resources